Clinical evaluation of tebipenem pivoxil in the treatment of child community-acquired bacterial pneumonia

Trial Profile

Clinical evaluation of tebipenem pivoxil in the treatment of child community-acquired bacterial pneumonia

Recruiting
Phase of Trial: Phase III

Latest Information Update: 12 May 2016

At a glance

  • Drugs Tebipenem pivoxil (Primary) ; Ampicillin; Sulbactam/ampicillin
  • Indications Community-acquired pneumonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top